ACR Insider Trading

Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): A$93,340.59
Insider Selling (Last 12 Months): A$0.00

Acrux Insider Trading History Chart

This chart shows the insider buying and selling history at Acrux by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Acrux Share Price & Price History

Current Price: A$0.00
Price Change: +0.30 (1.20%)
As of 05/13/2020 01:00 AM ET

This chart shows the closing price history over time for ACR up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table

Acrux Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/30/2022Donald BrumleyInsiderExercise59,555A$0.06A$3,573.30
6/22/2022Timothy OldhamInsiderExercise646,110A$0.07A$42,643.26
5/23/2022Donald BrumleyInsiderBuy57,614A$0.07A$4,090.59
3/15/2022Donald BrumleyInsiderExercise171,546A$0.09A$15,267.59
11/29/2021Donald BrumleyInsiderBuy750,000A$0.12A$89,250.00
11/26/2021Donald BrumleyInsiderIssued347,624A$0.12A$42,062.50
9/15/2021Ross DobinsonInsiderExercise81,944A$0.14A$11,472.16
6/15/2021Ross DobinsonInsiderExercise81,944A$0.12A$9,423.56
3/15/2021Ross DobinsonInsiderBuy81,944A$0.16A$12,701.32
2/4/2021Geoffrey BrookeInsiderIssued318,471A$0.16A$49,999.95
1/15/2021Ross DobinsonInsiderBuy80,000A$0.21A$16,800.00
12/15/2020Ross DobinsonInsiderBuy81,944A$0.18A$14,749.92
11/17/2020Norman GrayInsiderIssued699,999A$0.17A$118,999.83
9/15/2020Ross DobinsonInsiderExercise81,944A$0.19A$15,159.64
7/15/2020Ross DobinsonInsiderExercise81,944A$0.16A$13,111.04
3/16/2020Ross DobinsonInsiderExercise81,944A$0.12A$9,833.28
2/17/2020Ross DobinsonInsiderExercise160,000A$0.17A$27,200.00
1/15/2020Geoffrey BrookeInsiderIssued80,000A$0.20A$15,600.00
12/9/2019Ross DobinsonInsiderIssued983,334A$0.19A$186,833.46
10/3/2019Ross DobinsonInsiderBuy164,094A$0.19A$30,357.39
9/24/2019Ross DobinsonInsiderBuy33,892A$0.18A$6,202.24
9/20/2019Ross DobinsonInsiderBuy40,000A$0.18A$7,320.00
See Full Table

SEC Filings (Institutional Ownership Changes) for Acrux (ASX:ACR)

Acrux logo
Acrux Limited, together with its subsidiaries, develops and commercializes generic and topical pharmaceuticals in Australia, Europe, the United States, and internationally. The company offers testosterone solutions, such as oral tablets, buccal tablets, subcutaneous pellets, transdermal patches, injections, and topical gels for treatment of adult males who have low or no testosterone. It also provides estradiol sprays for women under the Evamist and Lenzetto brand names for the treatment of flushes associated with menopause. The company was incorporated in 1998 and is based in West Melbourne, Australia.
Read More on Acrux

Today's Range

Now: N/A

50 Day Range


52 Week Range

Now: N/A


4,000 shs

Average Volume


Market Capitalization


P/E Ratio


Dividend Yield




Who are the company insiders with the largest holdings of Acrux?

Acrux's top insider shareholders include:
  1. Donald Brumley (Insider)
  2. Geoffrey Brooke (Insider)
  3. Norman Gray (Insider)
  4. Ross Dobinson (Insider)
  5. Timothy Oldham (Insider)
Learn More about top insider investors at Acrux.